Intractable Pain

Abstract

Intractable pain is a type of pain: pain that persists and resists relief by ordinary treatment, the clinical name for suffering that outlasts its original cause and defeats the medicine aimed at it. Cognitive psychology matters to it because intractable pain is the clearest case in which pain is not a readout of the tissues but a state of the nervous system and the mind: it is sustained by central sensitization, kept in the foreground by pain's demand on attention, and shaped by how a person interprets and fears it. This article develops that account: the turn from tissue to nervous system, the interruptive function of pain, the argument that pain intensity is the wrong measure of treatment success, and the psychological therapies that follow from taking the mind seriously in pain that will not stop.

Keywords: intractable pain, central sensitization, chronic pain, pain catastrophizing, attention

Some pain does its job and stops. It warns of injury, guards the healing tissue, and fades as the tissue mends. Intractable pain is what remains when that arc breaks: pain that continues long after any wound has closed, or that never had a wound to begin with, and that ordinary analgesia, surgery, and rest fail to relieve. It is the hardest problem in pain medicine precisely because it cannot be explained, or fixed, as a reading of damaged tissue. The last half-century of pain science has shown why — that pain is constructed by the nervous system rather than transmitted from the body (Melzack & Wall, 1965), that the system can turn up its own gain until it produces pain from little or no input (Woolf & Salter, 2000), and that what a person attends to, expects, and fears becomes part of the pain itself (Eccleston & Crombez, 1999). That is what makes intractable pain, a medical condition, squarely a subject for cognitive psychology.

What Intractable Pain Is

Intractable pain is defined by its refractoriness rather than by any single cause or location: pain that persists and cannot be adequately relieved by standard treatment. The term is old and somewhat clinical, once attached to the pain of advanced cancer and to the legal frameworks governing opioid prescribing, but its core meaning is the pain that does not yield. It overlaps heavily with chronic pain — pain persisting beyond the expected period of healing, conventionally more than three months — while adding the further claim that ordinary measures have failed. What both share, and what separates them from ordinary acute pain, is that the pain has come loose from the tissue state it once reported.

That decoupling is the crux. Nociception, the detection of actually or potentially damaging stimuli by specialized sensory neurons, is neither necessary nor sufficient for pain: people with severe tissue injury can feel little, and people with no detectable injury can feel agony. Modern classification has caught up with this. The eleventh revision of the International Classification of Diseases now treats chronic pain as a diagnosis in its own right rather than a mere symptom of something else, giving persistent and intractable pains a formal home as conditions to be understood and treated directly (Treede et al., 2019). Alongside that, pain science has added a third mechanistic category — nociplastic pain, arising from altered nociceptive processing without clear evidence of tissue damage or a lesion of the somatosensory system — to sit beside the older nociceptive and neuropathic types, precisely to name the intractable pain that neither injury nor nerve damage explains (Kosek et al., 2016). Table 1 sets out the three mechanistic categories and shows why intractable pain so often belongs to the last of them. Understanding why such pain arises, and why it resists treatment, is where cognitive psychology enters.

From Tissue to Nervous System

The intellectual turn that made intractable pain comprehensible began with the gate control theory. Melzack and Wall proposed that pain is not a straight-through transmission from the body to the brain but is modulated at the spinal cord, where a gate can be opened or closed by other sensory input and, crucially, by signals descending from the brain (Melzack & Wall, 1965). This descending modulation — the brain's capacity to amplify or suppress incoming pain signals according to attention, expectation, and emotion — meant that pain could no longer be read as a fixed function of injury. Melzack later generalized the idea into the neuromatrix theory: that the experience of pain is generated by a widely distributed network in the brain, so that pain can be produced by the network itself even in the absence of any input from the body, as in phantom-limb pain.

The mechanism that turns this from possibility into the engine of intractable pain is central sensitization. Woolf and Salter described it as an increase in the gain of the pain system: sustained input alters the excitability of central nociceptive neurons, so that the same stimulus now produces a larger response, and inputs that were previously innocuous begin to produce pain (Woolf & Salter, 2000). Its two clinical signatures follow directly. Hyperalgesia is heightened pain from a stimulus that is normally painful; allodynia is pain from a stimulus that is normally not painful at all, such as light touch or the brush of clothing. Once the system's gain is turned up, the pain becomes self-sustaining: it is maintained by the state of the nervous system rather than by any ongoing damage, which is exactly why removing or treating the original site so often fails (Woolf, 2011). The first demonstration makes this concrete, letting the stimulus intensity and the system's gain be set independently to show how a sensitized system turns ordinary or even trivial input into severe pain.

Figure 1

How Central Sensitization Shifts the Stimulus–Response Curve

This reframing dissolves an old puzzle. If pain measured tissue damage, intractable pain with no visible cause would be a contradiction or a fabrication. Once pain is understood as an output of a nervous system whose gain can be raised and locked high, pain without a lesion is not only possible but expected, and the failure of treatments aimed at the periphery is not a mystery but a prediction. Human brain-imaging work has since confirmed that the chronic pain state involves reorganized activity in networks handling attention, emotion, and salience, not merely the sensory relay of nociception (Apkarian et al., 2005).

Pain That Demands Attention

If central sensitization explains why intractable pain persists, the cognitive account of attention explains why it dominates a life. Eccleston and Crombez argued that pain is fundamentally an interruptive signal: its biological purpose is to demand attention, to break off whatever a person is doing and reprioritize the body's protection (Eccleston & Crombez, 1999). This is adaptive for acute pain, where the interruption is brief and useful. In intractable pain the same mechanism becomes a trap: a signal designed to seize attention now does so continuously, so that the pain is perpetually in the foreground, competing with concentration, memory, conversation, and work. The urgency of the interruption is set not by intensity alone but by the pain's threat value — how novel, unpredictable, and menacing it seems — which is why a pain interpreted as a sign of serious disease captures attention far more completely than an identical sensation understood as benign.

Pain interference — the degree to which pain disrupts activities, mood, sleep, and relationships — is the downstream cost of this chronic capture, and it is often what patients mean when they say the pain has taken over. The second demonstration models the interruption directly, letting the pain's intensity and its threat value be set to show how much of a person's limited attention is captured and how that capture degrades performance on whatever else they are trying to do.

The engine that turns up the threat value is pain catastrophizing: an exaggerated negative orientation toward actual or anticipated pain, marked by rumination, magnification, and helplessness. Measured by the Pain Catastrophizing Scale, it is among the most robust psychological predictors of pain intensity, disability, and poor treatment response across pain conditions (Sullivan et al., 1995). Catastrophizing feeds the attentional system exactly the appraisal that maximizes interruption — that the pain is dangerous, uncontrollable, and worsening — and so binds attention more tightly to it, in a loop that both amplifies the felt pain and deepens its hold on awareness. The fear-avoidance model formalizes where this loop leads: catastrophic interpretation of pain breeds pain-related fear, which drives avoidance of activity and hypervigilance to bodily sensation, and that avoidance in turn produces disuse, disability, and depression that feed back into more pain — the pathway by which a painful sensation becomes an intractable, disabling condition (Vlaeyen & Linton, 2000). This is why intractable pain is so corrosive to cognition and mood, and why treatments that change the appraisal of pain can reduce its grip without changing the nociceptive input at all.

Is Intensity the Wrong Metric?

The recognition that intractable pain is a state of the nervous system and the mind has forced a hard question about how success is measured. For decades the goal of pain treatment, and the endpoint of pain trials, has been reduction in pain intensity, the number a patient gives on a zero-to-ten scale. Ballantyne and Sullivan argued that for chronic and intractable pain this is the wrong metric: intensity is a poor guide to how much a life is damaged, and chasing it — especially with escalating opioids — can leave patients no better, or worse, on the outcomes that actually matter, such as function, mood, and participation in life (Ballantyne & Sullivan, 2015). A treatment that lowers a pain score while a person remains housebound, depressed, and dependent has not succeeded in any meaningful sense; a treatment that leaves the score unchanged but returns the person to work and family may have succeeded completely.

This argument is the practical face of the whole cognitive account. If pain were a tissue readout, intensity would be the natural measure. Because pain is a multidimensional experience woven from sensation, attention, emotion, and meaning, a single intensity number captures only one thread and can mislead about the rest. The move toward mechanism-based and multidimensional assessment — classifying pain by the process generating it and measuring outcomes across function and well-being rather than intensity alone — follows directly (Vardeh et al., 2016). The third demonstration makes the mismatch concrete, letting a patient's change in pain intensity be set separately from their change in interference, mood, and activity, and showing how a treatment judged a success by the intensity metric can be judged a failure by a functional one, and the reverse.

Worked Example

Consider the two-metric comparison the third demonstration computes, and use it to show how the choice of outcome measure can reverse a judgment about whether treatment worked. Score a patient before and after treatment on four zero-to-ten dimensions: pain intensity, pain interference (how much pain disrupts daily life), mood, and activity. Judge success two ways. The intensity metric is simply the drop in the pain score. The functional metric is a composite F = 0.4 × (10 − interference) + 0.3 × mood + 0.3 × activity, scaled to a zero-to-ten score in which higher is better.

Take Patient A. Before treatment their pain intensity is 8, interference 8, mood 3, activity 2. After an opioid escalation their intensity falls to 5, but interference stays at 8, mood at 3, and activity at 2. By the intensity metric this is a clear success: the score fell by 3 points. By the functional metric, F = 0.4 × (10 − 8) + 0.3 × 3 + 0.3 × 2 = 0.8 + 0.9 + 0.6 = 2.3, essentially unchanged and low — the life is no better.

Now take Patient B, starting from the same profile. After a course of multidisciplinary rehabilitation their pain intensity falls only from 8 to 7, but interference drops to 3, mood rises to 7, and activity to 7. By the intensity metric this looks like near-failure: the score fell by just 1 point, a third of Patient A's improvement. By the functional metric, F = 0.4 × (10 − 3) + 0.3 × 7 + 0.3 × 7 = 2.8 + 2.1 + 2.1 = 7.0, a large gain.

The two metrics rank the patients in opposite orders. By intensity, Patient A (−3) did far better than Patient B (−1). By function, Patient B (7.0) did far better than Patient A (2.3). Nothing about the arithmetic is subtle; the point is that the choice of what to measure decides who counts as helped, and for intractable pain the intensity number — the one that is easiest to collect and that most trials report — is the one most likely to mislead (Ballantyne & Sullivan, 2015). This is the quantitative shape of the argument that treating intractable pain means restoring function and well-being, not merely lowering a number.

Discussion

The study of intractable pain has undergone the same migration as pain science as a whole: from the tissues into the nervous system and the mind. The biomedical model located pain in damaged tissue and treated intractable pain as a failure to find and fix the lesion; the accumulating evidence that pain is constructed by the nervous system (Melzack & Wall, 1965), that the system amplifies its own signal through central sensitization (Woolf & Salter, 2000; Woolf, 2011), and that attention, appraisal, and emotion are constitutive of the experience (Eccleston & Crombez, 1999; Apkarian et al., 2005) forced a wholesale reframing. Intractable pain is the condition in which that reframing matters most, because it is exactly the pain that the tissue model cannot explain and cannot cure.

The reframing has changed both classification and treatment. Chronic pain is now a diagnosis in its own right (Treede et al., 2019), the nociplastic category names the intractable pain that neither injury nor nerve lesion explains (Kosek et al., 2016), and the field is moving toward mechanism-based diagnosis and multidimensional outcomes rather than intensity alone (Vardeh et al., 2016; Ballantyne & Sullivan, 2015). Treatment has followed: because the drivers of intractable pain are neural and psychological, the evidence favors multidisciplinary care that combines medical management with cognitive and behavioral treatment aimed at the meaning, attention, and function surrounding the pain (Turk et al., 2011). Psychological therapies, chiefly cognitive-behavioral, produce modest but real reductions in pain, disability, and distress in chronic pain (Williams et al., 2020) — modest because they are working against a sensitized nervous system and an entrenched attentional habit, real because those are, in the end, the right targets. The cognitive psychology of intractable pain is not an adjunct to its management but the core of it: the factors that make pain intractable, and the levers that can loosen its grip, lie substantially in how the nervous system and the mind construct and sustain the experience (Cohen et al., 2021).

Current Directions

Current research on intractable pain is organized around the mechanistic reframing and its clinical payoff. One central strand is the consolidation of nociplastic pain as a diagnosable mechanism, with the effort now focused on identifying the clinical signatures and biomarkers of a sensitized nervous system so that intractable pain can be classified by the process generating it rather than by the failure of previous treatments (Kosek et al., 2016; Vardeh et al., 2016). A parallel line follows the ICD-11 recognition of chronic pain as a disease into practice, working out how a diagnosis defined at the level of the person, rather than the lesion, should reshape assessment and care (Treede et al., 2019; Cohen et al., 2021). The most consequential shift is in outcomes: driven by the argument that intensity is the wrong metric and by the harms of opioid escalation, trials and guidelines increasingly measure function, mood, and participation, and favor multidisciplinary and psychologically informed treatment over dose escalation (Ballantyne & Sullivan, 2015; Turk et al., 2011). Refining psychological therapies — improving their effect sizes, matching them to mechanism, and delivering them at scale — remains an active and unfinished project (Williams et al., 2020). The enduring lesson is the one the field has been drawing for sixty years: pain that will not stop is rarely a problem of the tissues alone, and its treatment must reach the nervous system and the mind that sustain it.

Common Misconceptions

If no injury can be found, intractable pain must be imaginary.

Pain without a lesion is exactly what a sensitized nervous system produces; the pain is generated by the raised gain of central pain-processing neurons, not by imagination, and it is entirely real (Woolf & Salter, 2000; Kosek et al., 2016).

The goal of treatment is always to lower the pain score.

For intractable pain, pain intensity is a poor measure of how much a life is damaged; a treatment that restores function and mood while barely changing the score can be a greater success than one that lowers the score but leaves the person disabled (Ballantyne & Sullivan, 2015).

Because psychology helps, the pain is psychological rather than physical.

Attention, appraisal, and emotion are part of the neural machinery that generates all pain, so psychological treatment works on the same system as any other therapy; that it helps says nothing about the pain being less real or less physical (Eccleston & Crombez, 1999; Williams et al., 2020).

Glossary

Allodynia.

Pain provoked by a stimulus that is normally not painful at all, such as light touch; a clinical signature of central sensitization.

Central sensitization.

An increase in the excitability, or gain, of nociceptive neurons in the central nervous system, so that pain is amplified and can be produced by ordinary or absent input; the principal mechanism by which pain becomes self-sustaining and intractable.

Chronic pain.

Pain that persists beyond the expected period of healing, conventionally more than three months; intractable pain is chronic pain that has also resisted ordinary treatment.

Descending modulation.

The brain's capacity to amplify or suppress incoming pain signals via pathways descending to the spinal cord, according to attention, expectation, and emotion; the route by which the mind influences pain.

Fear-avoidance model.

The account of how catastrophic interpretation of pain breeds pain-related fear and avoidance of activity, which in turn produce disuse, disability, and distress that feed back into more pain; the canonical pathway from a painful sensation to a disabling condition.

Gate control theory.

Melzack and Wall's theory that spinal-cord circuits gate the transmission of pain signals to the brain, opening pain science to the influence of other sensory input and of descending brain control.

Hyperalgesia.

Heightened pain from a stimulus that is normally painful; together with allodynia, a hallmark of a sensitized pain system.

Intractable pain.

Pain that persists and cannot be adequately relieved by standard treatment; defined by its refractoriness rather than by any single cause or location.

Neuromatrix.

Melzack's proposal that pain is generated by a widely distributed brain network, so that the experience can be produced by the network itself even without input from the body, as in phantom-limb pain.

Neuropathic pain.

Pain caused by a lesion or disease of the somatosensory nervous system itself, such as nerve injury or postherpetic neuralgia; a frequently persistent category and a common source of intractable pain.

Nociception.

The detection of actually or potentially damaging stimuli by specialized sensory neurons; distinct from pain, which is the conscious experience the nervous system may or may not construct from it.

Nociplastic pain.

Pain arising from altered nociceptive processing without clear evidence of tissue damage or a lesion of the somatosensory system; the third mechanistic category, alongside nociceptive and neuropathic pain, that names much intractable pain.

Pain catastrophizing.

An exaggerated negative orientation toward actual or anticipated pain, marked by rumination, magnification, and helplessness, and among the strongest psychological predictors of pain-related disability.

Pain interference.

The degree to which pain disrupts activities, mood, sleep, and relationships; a functional outcome that often captures the harm of intractable pain better than pain intensity does.

Phantom-limb pain.

Pain felt in a limb that has been amputated, produced by the brain's pain network in the absence of any input from the missing part; a demonstration that pain can be generated centrally rather than read from the body.

Key Researchers

Jane C. Ballantyne (contemporary). Anesthesiologist and pain physician at the University of Washington, a leading critic of long-term opioid therapy for chronic pain and co-author of the argument that pain intensity is the wrong metric for judging treatment success. Faculty page - Google Scholar

Christopher Eccleston (contemporary). Health psychologist at the University of Bath whose cognitive-affective model of pain as an interruptive, attention-demanding signal, and whose Cochrane syntheses of psychological therapies, underpin the cognitive account of why pain persists and disables. ORCID - Faculty page

Ronald Melzack (1929-2019). Psychologist at McGill University who, with Patrick Wall, introduced the gate control theory of pain and later the neuromatrix theory, establishing that pain is constructed by the nervous system rather than read off the tissues — the conceptual root of intractable pain. Wikipedia - Google Scholar

Rolf-Detlef Treede (contemporary). Neurophysiologist at Heidelberg University who chaired the IASP task force behind the ICD-11 classification of chronic pain, which gives intractable and other persistent pains a formal diagnostic home as conditions in their own right. ORCID - Faculty page

Dennis C. Turk (contemporary). Clinical psychologist at the University of Washington and a founder of the multidisciplinary, cognitive-behavioral model of chronic pain management, and co-author of the Lancet synthesis on treating chronic non-cancer pain. Faculty page - Google Scholar

Clifford J. Woolf (contemporary). Neurobiologist at Harvard Medical School and Boston Children's Hospital who identified central sensitization and, with Salter, framed it as an increase in the gain of the pain system — the mechanism that makes pain outlast its cause and resist peripheral treatment. ORCID - Faculty page

Frequently Asked Questions

What is intractable pain? Intractable pain is pain that persists and cannot be adequately relieved by standard treatment. It is defined by its refractoriness rather than by a particular cause or location, and it overlaps heavily with chronic pain while adding the further claim that ordinary measures have failed (Treede et al., 2019).

How is intractable pain different from chronic pain? Chronic pain is pain persisting beyond the normal period of healing, conventionally more than three months. Intractable pain is chronic pain that has also resisted ordinary treatment, so every intractable pain is chronic but not every chronic pain is intractable (Cohen et al., 2021).

Why doesn't intractable pain go away when the injury heals? Because it is maintained by the nervous system rather than by the original injury. Central sensitization raises the gain of central pain-processing neurons, so the system keeps producing pain from ordinary or even absent input long after any tissue has healed (Woolf & Salter, 2000; Woolf, 2011).

Can there be real pain with no detectable damage? Yes. Nociplastic pain arises from altered nociceptive processing without clear evidence of tissue damage or a nerve lesion, and phantom-limb pain shows that a brain network can generate pain with no input from the body at all. Such pain is generated by the nervous system and is entirely real (Kosek et al., 2016; Melzack & Wall, 1965).

Why is pain so hard to ignore? Because pain is built to interrupt. Its biological function is to seize attention and reprioritize protection of the body, and in intractable pain that interruption becomes chronic, holding the pain in the foreground and competing with everything else a person tries to do (Eccleston & Crombez, 1999).

Does catastrophizing make pain worse? Yes. Pain catastrophizing, meaning rumination, magnification, and helplessness about pain, is among the strongest psychological predictors of pain intensity, disability, and poor treatment response, in part because it feeds the attentional system the appraisal that most tightly binds attention to the pain (Sullivan et al., 1995).

Is lowering the pain score the right goal of treatment? Not on its own. For intractable pain, intensity is a poor measure of how much a life is damaged; restoring function, mood, and participation can matter far more, and chasing the score with escalating drugs can leave a person no better or worse on the outcomes that count (Ballantyne & Sullivan, 2015).

What treatments actually help intractable pain? Because the drivers are neural and psychological, the best evidence supports multidisciplinary care that combines medical management with cognitive-behavioral treatment aimed at the meaning, attention, and function surrounding the pain. Psychological therapies produce modest but real reductions in pain, disability, and distress (Turk et al., 2011; Williams et al., 2020).

References